ペット用がん治療薬の世界市場：市場規模、治療法別、投与経路別、生物種別、用途別、産業分析レポート、地域展望、成長可能性、価格動向、競合市場シェア＆予測、2023年～2032年

世界におけるペット用がん治療薬の市場は、ペットケア費用の急増により、2032年まで大幅に成長すると予測されています。

また、動物の健康や福祉に関する飼い主の意識の高まりが、業界の成長をさらに後押ししています。

リンパ腫やメラノーマなど、ペットのがんが増加傾向にあることから、ペットのがん治療薬の需要は世界的に拡大しています。また、ペットの飼い主が動物のヘルスケアにお金をかける傾向が強まっていることから、特に先進国ではペットのがん治療に対するニーズが高まっています。

さらに、業界の主要企業は、戦略的パートナーシップやコラボレーションを通じて、市場における地位の強化を図っています。例えば、2021年6月、ベーリンガーインゲルハイムとWEHIは、調整されたタンパク質分解メカニズムによる抗がん剤治療の探索と設計のための提携を発表しました。この提携により、生物学、治療標的、タンパク質分解、創薬に関する知識を組み合わせて、がんを引き起こすタンパク質に焦点を当てることが可能になりました。

ペット用がん治療薬市場は、治療法、投与経路、生物種、用途、地域の観点で区分されています。

治療法に基づくと、標的療法分野は2032年までに1億6,300万米ドル以上の市場評価を獲得すると予想されます。個別化治療の普及と現在の進歩が、この分野の成長を支える主要因となっています。さらに、ペットの腫瘍研究開発能力は、さまざまな企業の潜在能力を向上させると予想されています。これらの開拓により、市場の拡大が大幅に加速されると予測されます。

用途別では、メラノーマ領域が、調査期間中に大きな成長を遂げると予想されています。ペットのメラノーマ症例の急増が、事業成長を促進する主要なレンダリング要因となっています。米国国立生物工学情報センター（NCBI）によると、2017年に犬のすべての口腔がんの14.4％から45.5％を占めた犬メラノーマは、最も一般的な口腔悪性腫瘍と考えられています。

アジア太平洋地域のペットがん治療薬市場は、ペットのがん有病率の増加やペットケア費用の高騰を背景に、2032年までに4,700万米ドルを超える評価を受けると推定されます。2020年の中国のペット産業に関する統計によると、同国におけるペットの犬の飼育数は5,222万頭を超えています。また、腫瘍はペット犬の一般的な疾患であり、有病率は0.282%から1.701%です。

目次

第1章 調査手法とスコープ

第2章 エグゼクティブサマリー

第3章 ペットがん治療薬の業界洞察

• 業界情勢の推移、2018年～2032年
• 業界への影響要因
  • 促進要因
    • ペットがんの増加
    • ペットの病気に対する飼い主の意識の高まり
    • ペットケア支出の増加
    • がん免疫療法をはじめとするペットがん治療薬の技術的進歩
    • 医学的なアンメットニーズが高く、強いポテンシャルがあります
  • 業界の潜在的リスク＆課題
    • ペットのがん治療薬に伴う副作用
    • 獣医師腫瘍科医の不足
• 成長性分析
  • セラピー別
  • 投与経路別
  • 種目別
  • アプリケーション別
• COVID-19影響分析
• 製品パイプラインの分析
• 規制状況について
  • 米国
  • 欧州連合
  • ブラジル
  • オーストラリア
  • インド
• ギャップ分析
• ポーター分析
• PESTLE分析

第4章 競合情勢、2021年

• イントロダクション
• 企業マトリックス分析、2021年
• 戦略ダッシュボード、2021年

第5章 ペットがん治療薬市場：治療法別

• 主な治療動向
• 化学療法
• 免疫療法
• 標的療法
• 併用療法

第6章 ペット用がん治療薬市場：投与経路別

• 主な投与経路の動向
• オーラル
• インジェクション

第7章 ペット用がん治療薬市場：生物種別

• 主要な生物種の動向
• ドッグス
• キャッツ

第8章 ペット用がん治療薬市場：用途別

• 主なアプリケーション動向
• リンパ腫
• 肥満細胞腫
• メラノーマ
• 乳腺・扁平上皮がん
• その他

第9章 ペットがん治療薬市場：地域別

• 主な地域動向
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • スウェーデン
  • スイス
  • オランダ
  • オーストリア
  • ポーランド
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • フィリピン
  • ニュージーランド
• ラテンアメリカ
  • ブラジル
  • メキシコ

第10章 企業プロファイル

• Zoetis, Inc.
• Elanco Animal Health
• Boehringer Ingelheim International GmbH
• Dechra Pharmaceuticals
• AB Science
• Qbiotics
• NovaVive, Inc.
• ELIAS Animal Health

DATA TABLES

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by therapy
• TABLE 3 Market revenue, by route of administration
• TABLE 4 Market revenue, by species
• TABLE 5 Market revenue, by application
• TABLE 6 Market revenue, by region
• TABLE 7 Global pet cancer therapeutics market, 2018 - 2022 (USD Million)
• TABLE 8 Global pet cancer therapeutics market, 2023 - 2032 (USD Million)
• TABLE 9 Global pet cancer therapeutics market, by therapy, 2018 - 2022 (USD Million)
• TABLE 10 Global pet cancer therapeutics market, by therapy, 2023 - 2032 (USD Million)
• TABLE 11 Global pet cancer therapeutics market, by route of administration, 2018 - 2022 (USD Million)
• TABLE 12 Global pet cancer therapeutics market, by route of administration, 2023 - 2032 (USD Million)
• TABLE 13 Global pet cancer therapeutics market, by species, 2018 - 2022 (USD Million)
• TABLE 14 Global pet cancer therapeutics market, by species, 2023 - 2032 (USD Million)
• TABLE 15 Global pet cancer therapeutics market, by application, 2018 - 2022 (USD Million)
• TABLE 16 Global pet cancer therapeutics market, by application, 2023 - 2032 (USD Million)
• TABLE 17 Global pet cancer therapeutics market, by region, 2018 - 2022 (USD Million)
• TABLE 18 Global pet cancer therapeutics market, by region, 2023 - 2032 (USD Million)
• TABLE 19 Industry impact forces
• TABLE 20 Chemotherapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 21 Chemotherapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 22 Immunotherapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 23 Immunotherapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 24 Targeted therapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 25 Targeted therapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 26 Combined therapy market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 27 Combined therapy market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 28 Oral market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 29 Oral market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 30 Injection market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 31 Injection market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 32 Dogs market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 33 Dogs market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 34 Cats market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 35 Cats market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 36 Lymphoma market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 37 Lymphoma market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 38 Mast cell cancer market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 39 Mast cell cancer market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 40 Melanoma market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 41 Melanoma market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 42 Mammary and squamous cell cancer market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 43 Mammary and squamous cell cancer market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 44 Others market estimates and forecasts, 2018 - 2022, (USD Million)
• TABLE 45 Others market estimates and forecasts, 2023 - 2032, (USD Million)
• TABLE 46 North America pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 47 North America pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 48 North America pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 49 North America pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 50 North America pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 51 North America pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 52 North America pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 53 North America pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 54 North America pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 55 North America pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 56 U.S. pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 57 U.S. pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 58 U.S. pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 59 U.S. pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 60 U.S. pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 61 U.S. pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 62 U.S. pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 63 U.S. pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 64 Canada pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 65 Canada pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 66 Canada pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 67 Canada pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 68 Canada pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 69 Canada pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 70 Canada pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 71 Canada pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 72 Europe pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 73 Europe pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 74 Europe pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 75 Europe pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 76 Europe pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 77 Europe pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 78 Europe pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 79 Europe pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 80 Europe pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 81 Europe pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 82 Germany pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 83 Germany pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 84 Germany pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 85 Germany pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 86 Germany pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 87 Germany pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 88 Germany pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 89 Germany pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 90 UK pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 91 UK pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 92 UK pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 93 UK pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 94 UK pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 95 UK pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 96 UK pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 97 UK pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 98 France pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 99 France pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 100 France pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 101 France pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 102 France pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 103 France pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 104 France pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 105 France pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 106 Spain pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 107 Spain pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 108 Spain pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 109 Spain pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 110 Spain pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 111 Spain pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 112 Spain pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 113 Spain pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 114 Italy pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 115 Italy pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 116 Italy pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 117 Italy pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 118 Italy pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 119 Italy pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 120 Italy pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 121 Italy pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 122 Sweden pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 123 Sweden pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 124 Sweden pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 125 Sweden pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 126 Sweden pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 127 Sweden pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 128 Sweden pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 129 Sweden pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 130 Switzerland pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 131 Switzerland pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 132 Switzerland pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 133 Switzerland pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 134 Switzerland pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 135 Switzerland pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 136 Switzerland pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 137 Switzerland pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 138 The Netherlands pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 139 The Netherlands pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 140 The Netherlands pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 141 The Netherlands pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 142 The Netherlands pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 143 The Netherlands pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 144 The Netherlands pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 145 The Netherlands pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 146 Austria pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 147 Austria pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 148 Austria pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 149 Austria pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 150 Austria pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 151 Austria pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 152 Austria pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 153 Austria pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 154 Poland pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 155 Poland pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 156 Poland pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 157 Poland pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 158 Poland pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 159 Poland pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 160 Poland pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 161 Poland pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 162 Asia Pacific pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 163 Asia Pacific pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 164 Asia Pacific pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 165 Asia Pacific pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 166 Asia Pacific pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 167 Asia Pacific pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 168 Asia Pacific pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 169 Asia Pacific pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 170 Asia Pacific pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 171 Asia Pacific pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 172 China pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 173 China pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 174 China pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 175 China pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 176 China pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 177 China pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 178 China pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 179 China pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 180 India pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 181 India pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 182 India pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 183 India pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 184 India pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 185 India pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 186 India pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 187 India pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 188 Japan pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 189 Japan pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 190 Japan pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 191 Japan pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 192 Japan pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 193 Japan pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 194 Japan pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 195 Japan pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 196 Australia pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 197 Australia pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 198 Australia pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 199 Australia pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 200 Australia pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 201 Australia pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 202 Australia pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 203 Latin America pet cancer therapeutics market, by country, 2018 - 2022, (USD Million)
• TABLE 204 Latin America pet cancer therapeutics market, by country, 2023 - 2032, (USD Million)
• TABLE 205 Latin America pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 206 Latin America pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 207 Latin America pet cancer therapeutics market, by route of administration, 2018-2022, (USD Million)
• TABLE 208 Latin America pet cancer therapeutics market, by route of administration, 2023-2032, (USD Million)
• TABLE 209 Latin America pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 210 Latin America pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 211 Latin America pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 212 Latin America pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 213 Brazil pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 214 Brazil pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 215 Brazil pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 216 Brazil pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 217 Brazil pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 218 Brazil pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 219 Brazil pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 220 Brazil pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)
• TABLE 221 Mexico pet cancer therapeutics market, by therapy, 2018 - 2022, (USD Million)
• TABLE 222 Mexico pet cancer therapeutics market, by therapy, 2023 - 2032, (USD Million)
• TABLE 223 Mexico pet cancer therapeutics market, by route of administration, 2018 - 2022, (USD Million)
• TABLE 224 Mexico pet cancer therapeutics market, by route of administration, 2023 - 2032, (USD Million)
• TABLE 225 Mexico pet cancer therapeutics market, by species, 2018 - 2022, (USD Million)
• TABLE 226 Mexico pet cancer therapeutics market, by species, 2023 - 2032, (USD Million)
• TABLE 227 Mexico pet cancer therapeutics market, by application, 2018 - 2022, (USD Million)
• TABLE 228 Mexico pet cancer therapeutics market, by application, 2023 - 2032, (USD Million)

Charts & Figures

• FIG. 1 GMI Report Coverage: Critical research elements
• FIG. 2 Top-down approach
• FIG. 3 Breakdown of primary participants
• FIG. 4 Pet cancer therapeutics market industry 360 degree synopsis, 2018 - 2032
• FIG. 5 Industry landscape, 2018 - 2032 (USD Million)
• FIG. 6 Growth potential analysis, by therapy
• FIG. 7 Growth potential analysis, by route of administration
• FIG. 8 Growth potential analysis, by species
• FIG. 9 Growth potential analysis, by application
• FIG. 9 Gap analysis
• FIG. 10 Porter's analysis
• FIG. 11 PESTEL analysis
• FIG. 12 Company matrix analysis, 2021
• FIG. 13 Strategy dashboard, 2021

Global Pet Cancer Therapeutics Market is speculated to grow considerably through 2032 owing to the surging pet care expenses. Moreover, the rising awareness among pet owners regarding the health and well-being of animals has further bolstered industry growth.

The demand for pet cancer therapies is expanding globally due to the rising prevalence of pet cancers including lymphoma and melanoma, among many others. Also, the growing propensity of pet owners to spend money on animal healthcare is raising the need for cancer treatments for pets, particularly in industrialized nations.

In addition, the leading industry players are seeking to strengthen their position in the market through strategic partnership and collaboration. For instance, in June 2021, Boehringer Ingelheim and WEHI announced their partnership to explore and design anti-cancer therapies via a tailored protein degradation mechanism. The alliance enabled the firm to combine its knowledge of biology, therapeutic targeting, protein degradation, and drug discovery to focus on cancer-causing proteins.

The pet cancer therapeutics market has been divided in terms of therapy, route of administration, species, application, and region.

Based on therapy, the targeted therapy segment is expected to amass more than USD 163 million in market valuation by 2032. The rising use of personalized therapy and current advances are the primary drivers behind robust segmental growth. Additionally, it is anticipated that pet oncology R&D capabilities will improve the various companies' potential. Those developments are predicted to significantly accelerate market expansion.

With respect to application, the melanoma segment is set to attain sizable growth over the review period. The upsurge in melanoma cases amongst pets is the key rendering factor fueling business growth. According to the National Centers for Biotechnology Information (NCBI), canine melanoma, which made up 14.4% to 45.5% of all oral cancers in dogs in 2017, was thought to be the most common oral malignancy.

From the regional outlook, the Asia Pacific pet cancer therapeutics market is estimated to surpass over USD 47 million valuation by 2032 attributed to the increased prevalence of cancer among pets as well the skyrocketing pet care costs in the region. As per the statistics on China's pet industry in 2020, the pet dog adoption in the country has exceeded 52.22 million. Moreover, tumor has stood as a common disease in pet dog, with prevalence ranging from 0.282% to 1.701%.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Methodology
• 1.2 Market scope & definitions
• 1.3 Base estimates and working
  • 1.3.1 Data collection
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Pet cancer therapeutics industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Therapy trends
  • 2.1.3 Route of administration trends
  • 2.1.4 Species trends
  • 2.1.5 Applications trends
  • 2.1.6 Regional trends

Chapter 3 Pet Cancer Therapeutics Industry Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of pet cancer
    • 3.2.1.2 Growing awareness among pet owners regarding pet diseases
    • 3.2.1.3 Increasing pet care expenditure
    • 3.2.1.4 Technological advancements in pet cancer therapeutics including cancer immunotherapy
    • 3.2.1.5 High medical unmet need and strong potential
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Side effects associated with pet cancer therapeutics
    • 3.2.2.2 Lack of veterinary oncologists
• 3.3 Growth potential analysis
  • 3.3.1 By therapy
  • 3.3.2 By route of administration
  • 3.3.3 By species
  • 3.3.4 By application
• 3.4 COVID- 19 impact analysis
• 3.5 Product pipeline analysis
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 European Union
  • 3.6.3 Brazil
  • 3.6.4 Australia
  • 3.6.5 India
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTLE analysis

Chapter 4 Competitive landscape, 2021

• 4.1 Introduction
• 4.2 Company matrix analysis, 2021
• 4.3 Strategy dashboard, 2021

Chapter 5 Pet Cancer Therapeutics Market, By Therapy

• 5.1 Key therapy trends
• 5.2 Chemotherapy
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.3 Immunotherapy
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.4 Targeted therapy
  • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.5 Combination therapy
  • 5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Pet Cancer Therapeutics Market, By Route of Administration

• 6.1 Key route of administration trends
• 6.2 Oral
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.3 Injection
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Pet Cancer Therapeutics Market, By Species

• 7.1 Key species trends
• 7.2 Dogs
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.3 Cats
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Pet Cancer Therapeutics Market, By Application

• 8.1 Key application trends
• 8.2 Lymphoma
  • 8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.3 Mast cell cancer
  • 8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.4 Melanoma
  • 8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.5 Mammary and squamous cell cancer
  • 8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 8.6 Others
  • 8.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9 Pet Cancer Therapeutics Market, By Region

• 9.1 Key regional trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Sweden
  • 9.3.7 Switzerland
  • 9.3.8 The Netherlands
  • 9.3.9 Austria
  • 9.3.10 Poland
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Philippines
  • 9.4.7 New Zealand
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico

Chapter 10 Company Profiles

• 10.1 Zoetis, Inc.
• 10.2 Elanco Animal Health
• 10.3 Boehringer Ingelheim International GmbH
• 10.4 Dechra Pharmaceuticals
• 10.5 AB Science
• 10.6 Qbiotics
• 10.7 NovaVive, Inc.
• 10.8 ELIAS Animal Health